Elekta AB ser. B (EKTA-B.ST) Financials
EKTA-B.ST Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-01-31 | 30.7 billion | 20.5 billion |
2023-10-31 | 31.6 billion | 21.2 billion |
2023-07-31 | 30.8 billion | 20.6 billion |
2023-04-30 | 29.6 billion | 19.9 billion |
EKTA-B.ST Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-01-31 | 632.0 million | ? |
2023-10-31 | 211.0 million | ? |
2023-07-31 | -897.0 million | ? |
2023-04-30 | 1.6 billion | 25.0 million |
EKTA-B.ST Net Income
Date | Net Income |
---|---|
2024-01-31 | 306.0 million |
2023-10-31 | 442.0 million |
2023-07-31 | 305.0 million |
2023-04-30 | 688.0 million |
EKTA-B.ST Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-01-31 | 2.4 billion | - | 1.3 billion |
2023-10-31 | 1.9 billion | - | 1.0 billion |
2023-07-31 | 2.4 billion | 6.5 billion | 948.0 million |
2023-04-30 | 3.3 billion | 6.4 billion | 948.0 million |
EKTA-B.ST Shares Outstanding
EKTA-B.ST Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-01-31 | 440.0 million | 341.0 million | 346.0 million | 369.0 million |
2023-10-31 | 412.0 million | 323.0 million | 343.0 million | 427.0 million |
2023-07-31 | 346.0 million | 386.0 million | 314.0 million | 434.0 million |
2023-04-30 | 418.0 million | 305.0 million | 325.0 million | 399.0 million |
EKTA-B.ST Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-01-31 | 4.5 billion | 2.9 billion |
2023-10-31 | 4.7 billion | 3.0 billion |
2023-07-31 | 3.8 billion | 2.2 billion |
2023-04-30 | 5.1 billion | 3.2 billion |
EKTA-B.ST
Price: SEK76.95
Dividend Yield: 0.03%
Forward Dividend Yield: 3.12%
Payout Ratio: 64.00%
Dividend Per Share: 2.40 SEK
Earnings Per Share: 3.75 SEK
P/E Ratio: 21.16
Exchange: STO
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 32.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 20
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%